JP6529983B2 - マラリアの予防又は治療に有用なトリアミノピリミジン化合物 - Google Patents

マラリアの予防又は治療に有用なトリアミノピリミジン化合物 Download PDF

Info

Publication number
JP6529983B2
JP6529983B2 JP2016562579A JP2016562579A JP6529983B2 JP 6529983 B2 JP6529983 B2 JP 6529983B2 JP 2016562579 A JP2016562579 A JP 2016562579A JP 2016562579 A JP2016562579 A JP 2016562579A JP 6529983 B2 JP6529983 B2 JP 6529983B2
Authority
JP
Japan
Prior art keywords
methyl
cyclopropyl
fluoro
diamine
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016562579A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017514804A (ja
JP2017514804A5 (https=
Inventor
ピア モハメッド，シャフル ハミード
ピア モハメッド，シャフル ハミード
パティル，ヴィカス
ムルガン，カナン
ベラル，エクナス ヴィサ−ルラオ
ベラル，エクナス ヴィサ−ルラオ
レイチュルカル，アナンクマール
ランジ，スディル
パター，ジャヤシュリー
チョウドゥーリ，ニランジャナ ロイ
チョウドゥーリ，ニランジャナ ロイ
シャンブハッグ，ガジャーナン
コーシック，クリシュナ
アイヤル，プラヴィン
サムバンダマルシー，ヴァサン カルティカ
サムバンダマルシー，ヴァサン カルティカ
ソーラープル，スレシュ
ナラヤナン，シュリダール
Original Assignee
エムエムヴィ メディスィンズ フォー マラリア ヴェンチュアー
エムエムヴィ メディスィンズ フォー マラリア ヴェンチュアー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エムエムヴィ メディスィンズ フォー マラリア ヴェンチュアー, エムエムヴィ メディスィンズ フォー マラリア ヴェンチュアー filed Critical エムエムヴィ メディスィンズ フォー マラリア ヴェンチュアー
Publication of JP2017514804A publication Critical patent/JP2017514804A/ja
Publication of JP2017514804A5 publication Critical patent/JP2017514804A5/ja
Application granted granted Critical
Publication of JP6529983B2 publication Critical patent/JP6529983B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2016562579A 2014-04-28 2015-03-26 マラリアの予防又は治療に有用なトリアミノピリミジン化合物 Active JP6529983B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2142CH2014 2014-04-28
IN2142/CHE/2014 2014-04-28
PCT/EP2015/056496 WO2015165660A1 (en) 2014-04-28 2015-03-26 Triaminopyrimidine compounds useful for preventing or treating malaria

Publications (3)

Publication Number Publication Date
JP2017514804A JP2017514804A (ja) 2017-06-08
JP2017514804A5 JP2017514804A5 (https=) 2018-05-17
JP6529983B2 true JP6529983B2 (ja) 2019-06-12

Family

ID=52779638

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016562579A Active JP6529983B2 (ja) 2014-04-28 2015-03-26 マラリアの予防又は治療に有用なトリアミノピリミジン化合物

Country Status (22)

Country Link
US (1) US9957253B2 (https=)
EP (1) EP3137455B1 (https=)
JP (1) JP6529983B2 (https=)
CN (1) CN106255685B (https=)
AP (1) AP2016009570A0 (https=)
BR (1) BR112016024467B1 (https=)
CA (1) CA2946654C (https=)
CY (1) CY1120700T1 (https=)
DK (1) DK3137455T3 (https=)
ES (1) ES2696350T3 (https=)
HR (1) HRP20181816T1 (https=)
HU (1) HUE042043T2 (https=)
LT (1) LT3137455T (https=)
MX (1) MX374458B (https=)
MY (1) MY178971A (https=)
PH (1) PH12016502322B1 (https=)
PL (1) PL3137455T3 (https=)
PT (1) PT3137455T (https=)
RS (1) RS58124B1 (https=)
SI (1) SI3137455T1 (https=)
SM (1) SMT201800588T1 (https=)
WO (1) WO2015165660A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105699584B (zh) * 2016-02-03 2018-02-09 昆药集团股份有限公司 一种蒿甲醚相关物质的检测方法
WO2018079629A1 (ja) 2016-10-26 2018-05-03 カルナバイオサイエンス株式会社 抗マラリア活性を有する新規ピリミジン誘導体
CN106727584A (zh) * 2017-02-08 2017-05-31 于贵庆 一种治疗骨病的药物组合物
JP2020532513A (ja) * 2017-09-05 2020-11-12 カディラ ヘルスケア リミティド トリアミノピリミジン化合物およびその中間体の調製方法
CN117327007B (zh) * 2023-09-26 2024-09-13 上海陶术生物科技有限公司 一种vt107的制备方法
WO2025115034A1 (en) * 2023-11-30 2025-06-05 Zydus Lifesciences Limited A process for the preparation of a triaminopyrimidine compound and novel intermediates thereof
EP4574143A1 (en) 2023-12-21 2025-06-25 Universität Regensburg Inhibitors of plasmodia remodeling enzymes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003286711A1 (en) * 2002-10-25 2004-05-13 Vertex Pharmaceuticals Incorporated Indazolinone compositions useful as kinase inhibitors
RU2405778C2 (ru) * 2004-09-30 2010-12-10 Тиботек Фармасьютикалз Лтд. 5-гетероциклилпиримидины, ингибирующие вич
WO2014058685A1 (en) * 2012-10-08 2014-04-17 Merck Sharp & Dohme Corp. Inhibitors of irak4 activity

Also Published As

Publication number Publication date
AP2016009570A0 (en) 2016-11-30
CA2946654A1 (en) 2015-11-05
MY178971A (en) 2020-10-26
CN106255685B (zh) 2019-08-20
EP3137455A1 (en) 2017-03-08
CN106255685A (zh) 2016-12-21
US20170050951A1 (en) 2017-02-23
RS58124B1 (sr) 2019-02-28
MX374458B (es) 2025-03-06
JP2017514804A (ja) 2017-06-08
PH12016502322B1 (en) 2022-03-23
PL3137455T3 (pl) 2019-01-31
MX2016014166A (es) 2017-02-14
PH12016502322A1 (en) 2017-01-30
BR112016024467B1 (pt) 2022-11-29
LT3137455T (lt) 2018-10-25
CA2946654C (en) 2022-08-23
EP3137455B1 (en) 2018-08-15
BR112016024467A2 (pt) 2017-08-15
WO2015165660A1 (en) 2015-11-05
HK1231478A1 (en) 2017-12-22
CY1120700T1 (el) 2019-12-11
SI3137455T1 (sl) 2019-01-31
US9957253B2 (en) 2018-05-01
HRP20181816T1 (hr) 2018-12-28
PT3137455T (pt) 2018-11-21
DK3137455T3 (en) 2018-12-10
SMT201800588T1 (it) 2019-01-11
ES2696350T3 (es) 2019-01-15
HUE042043T2 (hu) 2019-06-28

Similar Documents

Publication Publication Date Title
JP6529983B2 (ja) マラリアの予防又は治療に有用なトリアミノピリミジン化合物
TWI902715B (zh) 作為ｐａｒｐ７抑制劑的嗒酮
RU2720237C2 (ru) Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
JP7239562B2 (ja) 光学活性な架橋型環状２級アミン誘導体
CN108349910A (zh) 葡萄糖摄取抑制剂
HK1244453A1 (zh) 使用syk抑制剂对慢性移植物抗宿主病的治疗
CN106029666B (zh) 作为原生动物蛋白酶体抑制剂用于治疗寄生虫疾病例如利什曼病的[1,2,4]三唑并[1,5-a]嘧啶衍生物
AU2016269626B2 (en) Imidazo[1,2-b][1,2,4]triazine derivatives as antiparasitic agents
US20230108442A1 (en) Novel antimalarial agent containing heterocyclic compound
WO2015193228A1 (de) Bet-proteininhibitorische 1,4-dihydropyrido[3,4-b]pyrazinone mit para-substituierter aromatischer amino- oder ethergruppe
EP4061375B1 (en) Antimalarial agents
HUE033124T2 (en) New anti-malarial drugs
JP2025514848A (ja) 抗感染剤
OA18110A (en) Triaminopyrimidine compounds useful for preventing or treating malaria
HK1231478B (en) Triaminopyrimidine compounds useful for preventing or treating malaria
WO2026082160A1 (zh) Wee1蛋白降解剂及其应用
KR20260025059A (ko) 신규한 치환된 피리딘 유도체 화합물, 이의 제조방법, 및 이를 유효성분으로 포함하는 호흡기 질환의 예방 또는 치료용 약학적 조성물
WO2022169790A1 (en) Chemovaccination against plasmodium infection with selective plasmepsin x inhibitors
CN117545747A (zh) 具有抗疟疾活性的杂环化合物的盐及其晶体
WO2016151521A1 (en) New substituted triazolopyrimidines as anti-malarial agents

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170316

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180323

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180323

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20181009

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181217

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190308

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190405

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190409

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190423

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190515

R150 Certificate of patent or registration of utility model

Ref document number: 6529983

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250